2714414-49-8
2714414-49-8
Chemical Structure
Medetomidine-d5 (d5-Major)
- CAS No.: 2714414-49-8
- Formula:C13H11D5N2
- Molecular Weight:205.31
InChIKey: CUHVIMMYOGQXCV-BLASSTDKSA-N
SMILES: CC1=C(C=CC=C1C([2H])(C([2H])([2H])[2H])C2=CN=C(N2)[2H])C
Biological Activity: Medetomidine-d5 (d5-Major) is the deuterium labeled Medetomidine (HY-17034). Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Medetomidine-d5 (d5-Major) | Medetomidine-d5 (d5-Major) is the deuterium labeled Medetomidine (HY-17034). Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Medetomidine (Standard) | ≥98% | Medetomidine (Standard) is the analytical standard of Medetomidine. This product is intended for research and analytical applications. Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Medetomidine | 99.75% | Medetomidine is an orally active α2-adrenoceptor agonist (Ki: 1.08 nM). Medetomidine has sedative and analgesic effects. Medetomidine can cause peripheral vasoconstriction through the activation of α2 adrenoceptors on blood vessels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
